8CVP

Cereblon-DDB1 in the Apo form

8CVP の概要

• エントリーDOI: 10.2210/pdb8cvp/pdb
• 関連するPDBエントリー: 8d7u 8d7v 8d7w 8d7x 8d7y 8d7z 8d80 8d81
• EMDBエントリー: 27012
• 分子名称: DNA damage-binding protein 1, Protein cereblon, ZINC ION (3 entities in total)
• 機能のキーワード: ubiquitin, crl4, adaptor, cereblon, ligase
• 由来する生物種: Homo sapiens (human); 詳細
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 177766.55

構造登録者

Watson, E.R.,Lander, G.C. (登録日: 2022-05-18, 公開日: 2022-07-20, 最終更新日: 2025-05-21)

主引用文献

Watson, E.R.,Novick, S.,Matyskiela, M.E.,Chamberlain, P.P.,H de la Pena, A.,Zhu, J.,Tran, E.,Griffin, P.R.,Wertz, I.E.,Lander, G.C.
Molecular glue CELMoD compounds are regulators of cereblon conformation.
Science, 378:549-553, 2022

PubMed Abstract: Cereblon (CRBN) is a ubiquitin ligase (E3) substrate receptor protein co-opted by CRBN E3 ligase modulatory drug (CELMoD) agents that target therapeutically relevant proteins for degradation. Prior crystallographic studies defined the drug-binding site within CRBN's thalidomide-binding domain (TBD), but the allostery of drug-induced neosubstrate binding remains unclear. We performed cryo-electron microscopy analyses of the DNA damage-binding protein 1 (DDB1)-CRBN apo complex and compared these structures with DDB1-CRBN in the presence of CELMoD compounds alone and complexed with neosubstrates. Association of CELMoD compounds to the TBD is necessary and sufficient for triggering CRBN allosteric rearrangement from an open conformation to the canonical closed conformation. The neosubstrate Ikaros only stably associates with the closed CRBN conformation, illustrating the importance of allostery for CELMoD compound efficacy and informing structure-guided design strategies to improve therapeutic efficacy.

PubMed: 36378961
DOI: 10.1126/science.add7574

実験手法

ELECTRON MICROSCOPY (3.4 Å)